Hyperlipemia, Mixed Clinical Trial
Official title:
A Randomized, Open, Single-dose, 2x2x4 Replicate Crossover-design Clinical Trial to Evaluate the Safety and Pharmacokinetic Characteristics After Co-administration of UIC201806 and UIC201602 or Administration of UI018 in Healthy Volunteers
This Study is to evaluate the safety and pharmacokinetics of a fixed dose combination formulation and co-administration.
n/a